International Clinical Trial: A randomized, open-label, controlled, proof of concept trial to evaluate the efficacy of extra fine particle inhaled triple therapy in preventing progression to COPD in high-risk individuals with pre-COPD: a study protocol

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118322) titled 'A randomized, open-label, controlled, proof of concept trial to evaluate the efficacy of extra fine particle inhaled triple therapy in preventing progression to COPD in high-risk individuals with pre-COPD: a study protocol' on Feb. 4.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing General Aerospace Hospital (formerly the 731 Hospital of China Aerospace Science and Industry Corporation

Condition: Pro-COPD

Intervention: Treatment Group:Will receive Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Inhalation Aerosol, 2 inhalations twice daily. The invest...